TRIM29 and ovarian carcinoma: TRIM29 expression levels correlate with prognosis in OC and enhance CSC-like features in cisplatin-resistant OC cells; YTHDF1 promotes TRIM29 translation in an m6A-dependent manner which contributes to the stem cell-like phenotype in cisplatin-resistant ovarian cancer [94].